Login to Your Account



Other News To Note


Monday, February 4, 2013
• Antabio, of Lebege, France, said it received a €4.7 million (US$6.4 million) Wellcome Trust Seeding Drug Discovery Award to develop small-molecule drugs for the treatment of life-threatening infections caused by multidrug-resistant Gram-negative bacteria.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription